One Pot Stock Could Skyrocket With Looming Interstate Sales
A new bill in Congress would decriminalize marijuana nationally by removing cannabis from the federal government’s list of controlled substances. The law would also allow one established Seattle cannabis company to market across state lines for the first time – potentially setting off a bidding war that could blast this stock into the stratosphere!
Find Out Why This Could Be the #1 Pot Stock
Robert Carey, insider at Beyond Air
Robert Carey Insider Alerts

Get notified the next time Robert Carey buys or sells Beyond Air stock. Enter your email address below to get our daily insider buying and selling report.

Robert Carey Insider Information

Director of Beyond Air
Robert F. Carey is Independent Director of the Company. Mr. Carey served as executive vice president, chief business officer for Horizon Pharma plc, a biopharmaceutical company, from March 2014 to October 2019. Prior to that, he served as managing director and head of the healthcare investment banking group at JMP Securities LLC, a full-service investment bank from March 2003 to March 2014. Prior to JMP, Mr. Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities International, Inc. He has also held roles at Shearson Lehman Hutton and Ernst & Whinney. Mr. Carey also serves on the board of directors of Beyond Air, Inc. (formerly AIT Therapeutics, Inc.). Mr. Carey received his B.S. in accounting from the University of Notre Dame. The Nominating and Corporate Governance Committee and the Board believe that Mr. Carey’s extensive experience and knowledge in the healthcare investment banking industry, particularly with financings, global expansion and other strategic transactions by life-science companies, as well as his role in business development for a public biopharmaceutical company, provides the Board with valuable insight and contribution.

What is Robert Carey's net worth?

The estimated net worth of Robert Carey is at least $6.97 million as of June 17th, 2021. Mr. Carey owns 481,418 shares of Beyond Air stock worth more than $6,970,933 as of November 30th. This net worth estimate does not reflect any other assets that Mr. Carey may own. Learn More.

How do I contact Robert Carey?

The corporate mailing address for Mr. Carey and other Beyond Air executives is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. Beyond Air can also be reached via phone at (516) 665-8200.

Has Robert Carey been buying or selling shares of Beyond Air?

During the last ninety days, Robert Carey has bought $289,700.00 in Beyond Air stock. Most recently, on Monday, November 22nd, Robert Carey bought 10,000 shares of Beyond Air stock. The stock was acquired at an average cost of $12.05 per share, with a total value of $120,500.00.

Who are Beyond Air's active insiders?

Beyond Air's insider roster includes Douglas Beck (CFO), and Robert Carey (Director).

Are insiders buying or selling shares of Beyond Air?

In the last year, Beyond Air insiders bought shares 9 times. They purchased a total of 471,500 shares worth more than $2,721,150.00. In the last year, insiders at the sold shares 2 times. They sold a total of 43,164 shares worth more than $540,460.92. The most recent insider tranaction occured on November, 24th when Director Ron Bentsur sold 37,464 shares worth more than $506,887.92. Insiders at Beyond Air own 14.7 % of the company.

Information on this page was last updated on 11/24/2021.

Robert Carey Insider Trading History at Beyond Air

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Buy10,000$12.05$120,500.00View SEC Filing Icon  
11/19/2021Buy12,000$14.10$169,200.00View SEC Filing Icon  
6/17/2021Buy350,000$5.36$1,876,000.00481,418View SEC Filing Icon  
3/4/2021Buy17,000$5.70$96,900.00131,418View SEC Filing Icon  
See Full Table

Robert Carey Buying and Selling Activity at Beyond Air

This chart shows Robert Carey's buying and selling at Beyond Air by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Beyond Air Company Overview

Beyond Air logo
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company. It engages in the developing a nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The firm develops LungFit platform system, a generator and delivery system that produces nitric oxide from ambient air, eliminating the need for expensive and cumbersome cylinders. The company was founded in 2011 and is headquartered in Garden City, NY.
Read More

Today's Range

Now: $14.48
Low: $13.99
High: $16.41

50 Day Range

MA: $11.83
Low: $10.27
High: $15.61

2 Week Range

Now: $14.48
Low: $4.62
High: $16.41


976,009 shs

Average Volume

463,500 shs

Market Capitalization

$385.75 million

P/E Ratio


Dividend Yield



Investors See Opportunity in Huge Global Demand for Lithium
The global lithium market is projected to surge 500% due to a growing need for lithium-filled batteries. And one junior mining company in a renowned location in South America is in the right place at the right time to capitalize on this megatrend.
Put this company on your investing radar today.